COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
Year: 2021
Type: article
Abstract: Vaccines against COVID-19 (and its emerging variants) are an essential global intervention to control the current pandemic situation. Vaccines often cause adverse events; however, the vast majority of adverse events following immunization (AEFI) are a consequence of the vaccine stimulating a protective immune response, and not allergic in etiology. Anaphylaxis as an AEFI is uncommon, occurring at a rate of less than 1 per million doses for most vaccines. However, within the first days of initiating mass vaccination with the Pfizer-BioNTech COVID-19 vaccine BNT162b2, there were reports of anaphylaxis from the United Kingdom and United States. More recent data imply an incidence of anaphylaxis closer to 1:200,000 doses with respect to the Pfizer-BioNTech vaccine. In this position paper, we discuss the background to reactions to the current COVID-19 vaccines and relevant steps to mitigate against the risk of anaphylaxis as an AEFI. We propose a global surveillance strategy led by allergists in order to understand the potential risk and generate data to inform evidence-based guidance, and thus provide reassurance to public health bodies and members of the public.
Authors: Paul J. Turner, Ignacio J. Ansotegui, Dianne E. Campbell, Victoria Cardona, Motohiro Ebisawa, Yehia El-Gamal, Stanley Fineman, Mario Geller, Alexei Gonzalez-Estrada, Paul A. Greenberger, Agnes S.Y. Leung, Michael E. Levin, Antonella Muraro, Mario Sánchez Borges, Gianenrico Senna, Luciana K. Tanno, Bernard Yu-Hor Thong, Margitta Worm
Institutions: The University of Sydney, Imperial College London, IDCQ Hospitales y Sanidad, S.L.U., DBV Technologies (France), Vall d'Hebron Hospital Universitari, National Sagamihara Hospital, Ain Shams University, Emory University, Academia Nacional de Medicina, Mayo Clinic, Mayo Clinic in Florida, Northwestern University, Chinese University of Hong Kong, Prince of Wales Hospital, Prince of Wales Hospital, University of Cape Town, Azienda Ospedale - Università Padova, Centro Médico Docente La Trinidad, University of Verona, Sorbonne Université, Centre Hospitalier Universitaire de Montpellier, Hospital Sírio-Libanês, Equipe de Recherche en Epidémiologie Nutritionnelle, Centre de Recherche Épidémiologie et Statistique, Tan Tock Seng Hospital, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,420
OpenAlex ID: W3126621205
